| Bisphosphonates: from the laboratory to the clinic and back again RGG Russell, MJ Rogers Bone 25 (1), 97-106, 1999 | 2189* | 1999 |
| Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy RGG Russell, NB Watts, FH Ebetino, MJ Rogers Osteoporosis international 19, 733-759, 2008 | 1794 | 2008 |
| Nitrogen‐containing bisphosphonates inhibit the mevalonate pathway and prevent post‐translational prenylation of GTP‐binding proteins, including Ras SP Luckman, DE Hughes, FP Coxon, RGG Russell, MJ Dr. Rogers Journal of bone and mineral research 13 (4), 581-589, 1998 | 1558 | 1998 |
| Bisphosphonates: the first 40 years RGG Russell Bone 49 (1), 2-19, 2011 | 1398 | 2011 |
| An interleukin 1 like factor stimulates bone resorption in vitro M Gowen, DD Wood, EJ Ihrie, MKB McGuire, RGG Russell Nature 306 (5941), 378-380, 1983 | 1266 | 1983 |
| Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite GH Nancollas, R Tang, RJ Phipps, Z Henneman, S Gulde, W Wu, ... Bone 38 (5), 617-627, 2006 | 1118 | 2006 |
| Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo H Fleisch, R Graham, G Russell, MD Francis Science 165 (3899), 1262-1264, 1969 | 1020 | 1969 |
| Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation … JE Fisher, MJ Rogers, JM Halasy, SP Luckman, DE Hughes, ... Proceedings of the National Academy of Sciences 96 (1), 133-138, 1999 | 936 | 1999 |
| Denosumab and bisphosphonates: different mechanisms of action and effects R Baron, S Ferrari, RGG Russell Bone 48 (4), 677-692, 2011 | 856 | 2011 |
| Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo MD Francis, R Graham, G Russell, H Fleisch Science 165 (3899), 1264-1266, 1969 | 779 | 1969 |
| Production of collagenase and prostaglandins by isolated adherent rheumatoid synovial cells. JM Dayer, SM Krane, RG Russell, DR Robinson Proceedings of the National Academy of Sciences 73 (3), 945-949, 1976 | 749 | 1976 |
| Bisphosphonates: mode of action and pharmacology RGG Russell Pediatrics 119 (Supplement_2), S150-S162, 2007 | 684 | 2007 |
| Effect of pyrophosphate on hydroxyapatite and its implications in calcium homeostasis H Fleisch, RGG Russell, F Straumann Nature 212 (5065), 901-903, 1966 | 681 | 1966 |
| The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs KL Kavanagh, K Guo, JE Dunford, X Wu, S Knapp, FH Ebetino, ... Proceedings of the National Academy of Sciences 103 (20), 7829-7834, 2006 | 661 | 2006 |
| Production of osteocalcin by human bone cells in vitro. Effects of 1, 25 (OH) 2D3, 24, 25 (OH) 2D3, parathyroid hormone, and glucocorticoids JN Beresford, JA Gallagher, JW Poser, RGG Russell Metabolic Bone Disease and Related Research 5 (5), 229-234, 1984 | 627 | 1984 |
| Clodronate and liposome‐encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5′‐(β, γ‐dichloromethylene) triphosphate, by mammalian cells in vitro JC Frith, J Mönkkönen, GM Blackburn, RGG Russell, MJ Rogers Journal of Bone and Mineral Research 12 (9), 1358-1367, 1997 | 621 | 1997 |
| Effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) and dichloromethylene diphosphonate (Cl2MDP) on the calcification and resorption of cartilage and bone in … R Schenk, WA Merz, R Mühlbauer, RGG Russell, H Fleisch Calcified tissue research 11, 196-214, 1973 | 544 | 1973 |
| Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti‐tumour activity CM Shipman, MJ Rogers, JF Apperley, RGG Russell, PI Croucher British journal of haematology 98 (3), 665-672, 1997 | 525 | 1997 |
| Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow. DE Hughes, BR MacDonald, RG Russell, M Gowen The Journal of clinical investigation 83 (6), 1930-1935, 1989 | 488 | 1989 |
| A UK Consensus Group on management of glucocorticoid‐induced osteoporosis: an update R Eastell, DM Reid, J Compston, C Cooper, I Fogelman, RM Francis, ... Journal of internal medicine 244 (4), 271-292, 1998 | 485 | 1998 |
Frank H. EbetinoUniversity of Rochester, Rochester, NY在 ur.rochester.edu 的电子邮件经过验证
